Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) IN Patients With Type 2 Diabetes Mellitus In Serbia
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.467
https://www.valueinhealthjournal.com/article/S1098-3015(17)30801-X/fulltext
Title :
Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) IN Patients With Type 2 Diabetes Mellitus In Serbia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30801-X&doi=10.1016/j.jval.2017.08.467
First page :
A481
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
442